Compound ID | 1510

Update compound information

Secnidazole

Class: Nitroimidazole

Agent Type: Synthetic; Small molecule; Direct acting;
Spectrum of activity: Gram-positive
Mechanism of action: Reduced to toxic free-radicals once inside anaerobic bacteria
Target Pathogen: Active against Clostridioides difficile
Year first mentioned: 2003
Highest development stage: Approved by FDA in 2017
Development status: Approved
Chemical structure(s):
Click here for structure editor
Molecular weight: 185.18
Iso. SMILES: CC1=NC=C(N1CC(C)O)[N+](=O)[O-]
InChI Key: KPQZUUQMTUIKBP-UHFFFAOYSA-N
Can. SMILES: CC(CN1C(=NC=C1[N+](=O)[O-])C)O
InChI: InChI=1S/C7H11N3O3/c1-5(11)4-9-6(2)8-3-7(9)10(12)13/h3,5,11H,4H2,1-2H3
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/71815
Guide to Pharmacology: secnidazole
Citation: https://www.nature.com/articles/s41429-020-0288-3

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.